Quick Answer
TherapeuticsMD, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $69.96 million for the year ending 2022.
- TherapeuticsMD, Inc. showed an increase of +2,619.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
- This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on April 7, 2023.
- XBRL data for this metric is available from 2016 to 2022 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2016 to 2022), TherapeuticsMD, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 261.4%.
- Historical annual values: Fiscal year 2022: $69.96 million | Fiscal year 2021: $2.57 million | Fiscal year 2020: $64.87 million | Fiscal year 2019: $49.65 million | Fiscal year 2018: $16.10 million | Fiscal year 2017: $16.78 million | Fiscal year 2016: $19.36 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: